Take these into the exam room on paper or on your phone. Ask what is known about the product, whether it suits your puppy, and what other care is available.
A peptide links together small parts that also form proteins. FDA is short for Food and Drug Administration. It checks whether animal medicines meet its approval requirements. These notes draw on its rules and published studies, checked in September 2026.
Nothing here replaces the answer your own vet gives after seeing your puppy.
Tick each one off as the vet answers it. The order follows how a visit tends to run.
An approved dog medicine has a six-digit approval number on its packaging. The letters NADA identify a brand-name medicine; ANADA identifies a generic version. A generic works in the body as the brand-name version does, and has FDA approval too.
Anyone can type that number into the FDA's free database, Animal Drugs @ FDA, and see what it covers.
Compounded means mixed or changed by a vet or pharmacist for an animal's needs. The FDA suggests asking which kind of medicine is being offered: an approved brand, an approved generic, or a compounded medicine without FDA approval.
Source checked September 2026. FDA: approved or compounded pet drugs
This one is for the box or pouch you brought. The peptides most often sold for pets are TB-500, BPC-157, KPV and GHK-Cu.
On September 30, 2026, none of the four had FDA approval, conditional approval or an index listing for any animal.
Conditional approval means the FDA has checked that a medicine is safe and well made, but full proof it works is still being collected.
An index listing is permission to sell a drug for certain animals with small markets, such as ferrets; dogs cannot use this route.
"Research use only" describes lab work, not treatment for your puppy. Bring that wording to the vet along with the rest of the packaging.
In warning letters about products sold for people, the FDA treated them as drugs because of the sellers' claims, despite those label words. The wording alone is no permission to use the product as an animal medicine.
Rule and letters read September 2026. eCFR: what "intended use" means
Most BPC-157 research used rats and mice. A 2026 review of rat and mouse injury studies called for more lab work; it did not establish BPC-157 as a treatment.
The only dog studies found used healthy lab beagles while building a human wound drug. Those dogs tolerated it, but a lab test like that is no proof a product is fine for a pet.
The search found no puppy treatment study either. That missing evidence is worth asking about.
PubMed collects medical research papers. Searching it on September 30, 2026 found no study treating sick or hurt pet dogs or cats with BPC-157. That is a dated search result, not proof that every possible source was searched.
Search dated September 30, 2026. PubMed: the beagle study
Mixing a medicine for one animal is called compounding. Even when the starting point is an approved drug, the mixed result has no FDA approval of its own.
The part intended to make a medicine work is called its active ingredient. Bulk powder means that raw ingredient before it becomes a finished medicine.
Federal law permits compounding from a finished approved drug under set conditions; it does not permit making animal drugs from raw bulk powder.
The FDA has separate guidance on when it generally chooses not to act against compounding from raw ingredients. That policy has conditions and does not give a medicine legal approval.
The September 30, 2026 searches found no approved human or animal medicine containing BPC-157 or TB-500. A compounded version would therefore have to start with raw powder, outside the route for mixing from approved drugs.
The sources do not settle whether a particular BPC-157 or TB-500 prescription meets that policy's conditions.
For a proposed compounded medicine, the FDA suggests asking about an approved medicine with the same active ingredient instead. For BPC-157 and TB-500, the searches found no such approved alternative. The next question for the vet is what other treatment fits your puppy's problem.
Guidance read September 2026. FDA: animal drug compounding
A new medicine can react with others, or make an existing illness worse. Both are on the FDA's own list of topics for the vet.
Approved pet medicines print known drug clashes on the label. For KPV, GHK-Cu, TB-500 and BPC-157, no study of clashes in any animal was found.
Labels and searches read September 2026. FDA: questions for your vet
For dogs taking pain and swelling medicines called NSAIDs long term, the FDA suggests blood tests to check the liver and kidneys. It suggests checks before treatment and again at regular points. Your vet sets the checks for the particular medicine and puppy.
An unapproved peptide may have a package label, but it has no FDA-reviewed medicine instructions. There is no FDA-reviewed plan for checks or signs that mean treatment must stop.
Labels read September 2026. FDA: pain relievers for pets
The FDA's own list of questions for owners includes asking about other medicine options.
It also points out that thousands of FDA-approved medicines are open to vets, low-cost generics included.
A generic animal medicine is FDA-approved too. The FDA says it works in the animal's body the same way as the brand.
Source checked September 2026. FDA: approved or compounded pet drugs
For an approved medicine, a use outside its label is called off-label use. Federal rules for that use require a recent in-person exam or a visit to where the puppy lives; video alone cannot replace it.
State rules also apply, so the vet needs to explain both sets of rules for the proposed medicine.
Since January 1, 2024, California has accepted a live video exam to start the relationship under its own law. That still does not meet the federal in-person requirement for off-label use.
After a video-only start, California limits prescriptions to six months before another exam. Antimicrobials, medicines for infections, are limited to 14 days. Controlled drugs, which have extra legal restrictions, require an in-person exam or visit to where the animal lives.
State law read September 2026. California's vet telehealth law
What an approved dog medicine carries, set against what a peptide sold online for pets carries. Use the buttons to read one side at a time.
Approved dog medicineReads "Approved by FDA under NADA #" or "ANADA #", with a number anyone can check.
Peptide sold onlineNo approval line. Often a note saying the contents are not for veterinary use, or are for research use only.
Approved dog medicineThe maker had to show the FDA it works and is safe for one stated use in one kind of animal.
Peptide sold onlineNo treatment study in pet dogs found as of September 30, 2026.
Approved dog medicineThe maker must pass side-effect reports on to the FDA.
Peptide sold onlineMakers of unapproved animal drugs are not required to report side effects, so trouble can go unnoticed.
Approved dog medicineThe label lists warnings and known clashes with other drugs.
Peptide sold onlineNo study of clashes with other medicines in animals was found in the sources checked in September 2026.
Approved dog medicineThe maker must show the FDA that each batch comes out the same.
Peptide sold onlineLab tests of peptide products sold online or seized, all meant for people, have found wrong amounts, impurities and some with no peptide in them at all.
Approved dog medicineSome come with a Client Information Sheet written for owners.
Peptide sold onlineNo FDA-reviewed owner leaflet to guide checks or explain when to stop.
Point these out to the vet if you see them. None of them means a product is approved.
The one that counts
The line that does mean approval is "Approved by FDA under NADA #" or "ANADA #", and the number can be checked.
If your puppy reacts to anything, the FDA's advice is to reach the vet and get treatment, then report it.
The FDA wants to hear about problems with any animal drug, approved, unapproved or compounded.
With an approved medicine, the FDA's suggested route is a phone call to the maker, which is obliged to forward the report.
For an unapproved or compounded product, the route is Form FDA 1932a, sent by email to CVM1932a@fda.hhs.gov.
The FDA's page on reporting